CF PharmTech, Inc. (HKG:2652)

CF PharmTech Statistics

Total Valuation

CF PharmTech has a market cap or net worth of HKD 14.02 billion. The enterprise value is 13.77 billion.

Market Cap	14.02B
Enterprise Value	13.77B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CF PharmTech has 411.48 million shares outstanding.

Current Share Class	301.73M
Shares Outstanding	411.48M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	49.31%
Float	187.28M

Valuation Ratios

The trailing PE ratio is 471.04.

PE Ratio	471.04
Forward PE	n/a
PS Ratio	21.64
PB Ratio	13.63
P/TBV Ratio	14.08
P/FCF Ratio	n/a
P/OCF Ratio	130.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 181.60, with an EV/FCF ratio of -208.18.

EV / Earnings	462.66
EV / Sales	21.26
EV / EBITDA	181.60
EV / EBIT	n/a
EV / FCF	-208.18

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.08.

Current Ratio	2.08
Quick Ratio	1.73
Debt / Equity	0.08
Debt / EBITDA	1.11
Debt / FCF	-1.28
Interest Coverage	4.39

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	0.91%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.13M
Profits Per Employee	51,836
Employee Count	574
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.79M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	34.94
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.28
Average Volume (20 Days)	248,652

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CF PharmTech had revenue of HKD 647.51 million and earned 29.75 million in profits. Earnings per share was 0.08.

Revenue	647.51M
Gross Profit	517.75M
Operating Income	10.18M
Pretax Income	26.97M
Net Income	29.75M
EBITDA	70.35M
EBIT	10.18M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 333.72 million in cash and 84.49 million in debt, with a net cash position of 249.23 million or 0.61 per share.

Cash & Cash Equivalents	333.72M
Total Debt	84.49M
Net Cash	249.23M
Net Cash Per Share	0.61
Equity (Book Value)	1.03B
Book Value Per Share	2.77
Working Capital	241.74M

Cash Flow

In the last 12 months, operating cash flow was 107.78 million and capital expenditures -173.90 million, giving a free cash flow of -66.12 million.

Operating Cash Flow	107.78M
Capital Expenditures	-173.90M
Free Cash Flow	-66.12M
FCF Per Share	-0.16

Margins

Gross margin is 79.96%, with operating and profit margins of 1.57% and 4.60%.

Gross Margin	79.96%
Operating Margin	1.57%
Pretax Margin	4.16%
Profit Margin	4.60%
EBITDA Margin	10.87%
EBIT Margin	1.57%
FCF Margin	n/a

Dividends & Yields

CF PharmTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.21%
FCF Yield	-0.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CF PharmTech has an Altman Z-Score of -0.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.16
Piotroski F-Score	4